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A fundamental difference between drug tri-
als and surgical trials is that the latter involve 
a procedure and therefore the patient out-
come will depend on a complex interaction 
between surgeon, patient and the operating 
environment. With regards to the surgeon’s 
impact; the outcome will be influenced by 
their proficiency in the delivery of the proce-
dure. Surgical proficiency is known to 
depend on both the learning curve for a pro-
cedure and the case volume of the surgeon, 
i.e., it is necessary to both ascend the learn-
ing curve and to practice the procedure 
regularly.
The learning curve varies for different pro-
cedures. For instance for hip fracture fixation 
the operating time does not level off until the 
surgeon has done 20 to 30 of these opera-
tions.1 For reduction of uncomplicated con-
genitally dislocated hips it may be slightly 
fewer as the performance seems to level after 
10 to 20 procedures and can be accelerated 
with appropriate simulation training.2 For 
arthroscopy of the knee, a simulation study 
suggests that consultant level skills are not 
reached until 170 procedures have been car-
ried out.3 Thus although the actual number 
might vary, there will always be a certain 
number of cases a surgeon needs to have 
performed before his/her proficiency has pla-
teaued. From the ethical point of view, before 
offering a new procedure a surgeon should 
be confident that he/she will do sufficient 
cases to complete the learning curve.4
in some trials the condition for which the 
procedure is carried out and the learning 
curve would be expected to have been com-
pleted during orthopaedic training e.g pri-
mary hip replacement,5-8 closure of knee 
replacement wounds.9 Whereas in other 
studies the procedure is more specialised 
and the condition less common (e.g. pedicle 
lengthening for spinal stenosis); a surgeon is 
less likely to complete the learning curve dur-
ing training.10 in studies with low numbers.11 
it is particularly important to ensure that the 
learning curve has been completed. A more 
difficult issue occurs when a randomised trial 
is comparing a new with an established sur-
gical procedure, and the surgeons may well 
be on different points of the learning curve 
for the new and the established procedures. 
Then a crude comparison of the outcomes 
might be unfair to the new procedure, as it 
includes less experience with the new tech-
nique, and so incorporates more of the tran-
sient ascent to the plateau of that new 
learning curve. Some methodologists have 
developed the concept of expertise based tri-
als to partially address the problem of learn-
ing curves, such as that reported in Devereaux 
et al.12 Another view is that although it might 
be methodologically correct to adjust out the 
learning curve in an efficacy-based ran-
domised trial, if one is instead interested in 
the comparative effectiveness of two surgical 
procedures, the learning curve is part and 
parcel of that effectiveness – in the real world, 
the surgeons will have to ascend that learn-
ing curve on real patients, whose outcomes 
should count in the overall assessment of the 
two procedures.
Modelling of the learning curve has been 
discussed by several authors.13,14 and can 
help place the findings of a study in clinical 
context. However, it still remains that if clini-
cal trials include surgeons on the learning 
curve, they will be assessing the learning 
curve as well the procedure itself. Thus clini-
cal trials aimed at assessing the procedure 
should ensure that the surgeons included in 
the trial have all completed their learning 
curve. Currently, even well constructed and 
detailed trial protocols such as the WHiTE3 
study do not address this aspect.15 To ensure 
this is the case and that it is apparent, future 
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surgical trial protocols should state (1) the number of 
cases they consider a surgeon should have performed to 
complete the learning curve for that the procedure and 
(2) that all the surgeons contributing to that trial have 
completed that number of cases.
The second area that is known to affect outcome is 
case volume. Where a condition or procedure is rare 
then a multicentre study is entirely appropriate to ensure 
case ascertainment. However when a condition is com-
mon and a multicentre trial is conducted it is important 
that the total case burden for that condition at the local 
contributing site is known; to indicate that the site is 
experienced; and that case ascertainment is representa-
tive of the condition burden and not a very highly select 
subgroup thereof, particularly if the patient demograph-
ics do not match the general demographics of the study 
or local overall demographics for that condition. 
Furthermore it is important that for operative procedures, 
or indeed the conservative management of fractures that 
the expertise to perform the intervention is assessed.
Whilst considering the proFHEr study,16 ghert and 
Mckee17 draw attention to the fact that 66 surgeons oper-
ated on 125 patients over a two and a half year period, 
i.e., less than one patient per surgeon per year. To judge 
the proficiency of the participating surgeons it would 
have been very helpful to have data on the number of 
cases they were performing in total each year. other 
examples where this information would have been useful 
include studies looking at cemented versus uncemented 
hip replacement18 and at metal on metal resurfacing.19 
larger studies involving DvT prophylaxis have included 
recruitment in 27 countries but not specified the number 
of recruitment centres or the total number of the relevant 
arthroplasty performed at those centres.20 Thus as well as 
recording the usual recruitment and exclusions data it is 
important to understand the total population in these 
multicentre studies in order to draw appropriate conclu-
sions from the data.
The potential differences in outcome of complex sur-
gery delivered in high-volume centres as opposed to low 
volume centres has also be noted to be a potentially impor-
tant factor in the design of pragmatic surgical trials.21
Thus future surgical trial protocols should state in the 
protocol (1) the minimum surgical volume considered 
necessary to maintain proficiency and (2) the trial data 
should include the number of cases surgeons are doing 
per year outside the study as well as those within the study.
if this data is not reported it is impossible to judge 
whether any inferior results are attributable to the proce-
dure itself or to delivery of the procedure by the surgeon.
in summary, surgical trials should state; (i) in the pro-
tocol - the number of cases in the learning curve and (ii) 
the recommended annual surgical volume and (iii) when 
reporting the trial - that contributing surgeons have com-
pleted the learning curve and (iv) the number of cases of 
the study type performed by each surgeon both within 
and outside the study.
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